Remove 2016 Remove Communication Remove Process Improvement
article thumbnail

Oligonucleotides: A Cornerstone for Therapeutics & More

ISPE

Since 2016, drug approvals per clinical campaign have outpaced the average across all modalities, resulting in 11 FDA-approved therapies in that span. 5’-(E)-Vinylphosphonate: A Stable Phosphate Mimic Can Improve the RNAi Activity of siRNA-GalNAc Conjugates.” 11 (2 June 2016): 985–89. Brigham, et al. “5’-(E)-Vinylphosphonate:

article thumbnail

Environmental Sustainability in Biopharmaceutical Facility Design

ISPE

linear) design process is central to successfully attaining such comprehensive sustainability goals and project needs (see Figure 1). 646 of 2016, 27 and the GHG Standard Scope 2. January 2016. 646 of 2016. Regulations 2016, Amendment, Energy Efficiency. 7 An integrative (vs. Recycling the Impossible.” August 2018.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Streamlining Postapproval Submissions Using ICH Q12 & SCDM

ISPE

Following approval of an initial marketing application, postapproval changes are needed to ensure adequate supply, mitigate supply risk, expand patient market access, optimize manufacturing processes, improve analytical methods, and comply with new regulatory expectations. BioProcess International 14 (2016): 38–43. Smith, and R.

article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

12 April 2016. Pharmaceutical Processing World. Nature Communications 12, no. 65: Technology Transfer (revised 2022), aims to standardize the approach to technology transfers, which would include conducting risk assessments, process comparisons, and knowledge transfers. BioProcess International 14 (2016):38–43.

article thumbnail

An Evaluation of Postapproval CMC Change Timelines

ISPE

In addition to delaying optimization of manufacturing and controls, these types of long delays for approvals discourage continuous process improvements for approved products. On this basis, country approvals covering 2016–2020 were included in the analysis. You may unsubscribe from these ISPE communications at any time.